Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Category
Equity - Leveraged / Inverse
Sponsor
GraniteShares
Fund Family
Index
-
Index Weighting
Active/Passive
Expense
1.07%
Inverse/Leveraged
IPO
May 05, 2026
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
No / No
Tags
Tags
Tags
Tags
Tags
-
Tags
-
Tags
-
Sector/Theme
Region
SMA20
-5.14%
SMA50
-8.39%
SMA200
-9.76%
Return% 1Y
-
Return% 3Y
-
Return% 5Y
-
Return% 10Y
Return% SI
Flows% 1M
-0.00%
Flows% 3M
0.00%
Flows% YTD
0.00%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
7
AUM
646.16K
NAV/sh
52W High
25.28 -17.11%
52W Low
20.87 0.41%
Volatility
0.77% 1.00%
ATR (14)
0.32
RSI (14)
30.07
Beta
-
Rel Volume
0.00
Avg Volume
1.88K
Volume
0
Perf Week
-1.64%
Perf Month
-9.09%
Perf Quarter
-
Perf Half Y
-
Perf YTD
-16.58%
Perf Year
-
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Prev Close
20.95
Price
20.95
Change
0.00%
GraniteShares YieldBOOST Biotech ETF is designed to maximize weekly income by executing an options strategy focused primarily on selling short-term put options on leveraged exchange-traded funds that track the 3x daily performance of the biotechnology sector. The fund targets three times the income stream compared to standard options writing on its underlying industry exposure while providing capped secondary capital appreciation and implementing a discretionary downside protection layer.